Showing results (361-370 of 420) with videos related to
Sort By:
Pageof 42
Annals of Internal Medicine|February 1, 1980
Anatomic substages of stage III-A Hodgkin's disease. A collaborative studyR S Stein, H M Golomb, C H Diggs, et al.Cancer Treatment Reports|April 1, 1982
Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative studyR S Stein, H M Golomb, P H Wiernik, et al.Blood|October 1, 1987
HL-T, a new cell line derived from HL-60 promyelocytic leukemia cell cultures expressing terminal transferase and secreting suppressor activityE Paietta, R J Stockert, T Calvelli, et al.Leukemia & Lymphoma|June 28, 2001
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481)P H Wiernik, T Leong, M M Oken, et al.Leukemia|June 1, 1991
Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acidP H Wiernik, J P Dutcher, E Paietta, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1991
Large and small fibre type sensory dysfunction in patients with cancerR B Lipton, B S Galer, J P Dutcher, et al.Cancer|March 1, 1997
Development of two radioimmunoassays to detect paclitaxel in sera and in cerebrospinal, ascitic, and pleural fluidsK P O'Boyle, Y Wang, E L Schwartz, et al.Cancer Research|August 1, 1987
Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cellsS L Marcus, J P Dutcher, E Paietta, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokineticsJ Z Fuks, M J Egorin, J Aisner, et al.Blood|August 15, 1995
Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acidR E Gallagher, Y P Li, S Rao, et al.Pageof 42